The Interaction Between Atrial Fibrillation and Mitral Regurgitation: Insights from the CABANA Randomized Clinical Trial
Catheter ablation was superior to pharmacological therapy in rhythm control and may reduce MR severity over time. These findings highlight ablation's potential structural and symptomatic benefits, pending specifically designed clinical trials.
Authors
- Pieter Martens (ORCID: https://orcid.org/0000-0002-6036-2113)
- W.H. Wilson Tang (ORCID: https://orcid.org/0000-0002-8335-735X)
- Laurent Pison (ORCID: https://orcid.org/0000-0002-8518-3330)
- Philippe B. Bertrand (ORCID: https://orcid.org/0000-0001-6324-6874)
- Sebastiaan Dhont (ORCID: https://orcid.org/0000-0002-5615-3191)
- Wilfried Müllens (ORCID: https://orcid.org/0000-0001-9995-8590)
- Sébastien Deferm (ORCID: https://orcid.org/0000-0002-2215-8680)
- Pieter M. Vandervoort
- Jonas Erzeel
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Ziekenhuis Oost-Limburg (BE)
- Hasselt University (BE)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1002/ejhf.3668
- Citations
- 8
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 11.11
Funders
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- National Institutes of Health